FDA NDC Directory · JSON-LD · Markdown

Rezurock

NDC 79802-200 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namebelumosudil
Labeler / ManufacturerKadmon Pharmaceuticals, LLC
Marketing categoryNew Drug Application (innovator) · App NDA214783
Dosage form / routeTABLET · ORAL
Active ingredientsBELUMOSUDIL (200 mg/1)
Marketing started20210716
Package count1

External sources

Source: openFDA. Public-domain (CC0).